An important step in integrating the patient perspective into the drug development continuum is to understand the groups that represent these patients and how to appropriately and meaningfully engage with them. Industry partners face multiple challenges in understanding their environmental landscape from too many potential partners with varying objectives, to too few players in the space.
MK&A has actively cultivated and nurtured respectful relationships with patient, consumer and professional groups for over 20 years. Through our modernized environmental assessment platform, LEAD, we offer our expertise and knowledge of the patient and professional organization landscape providing key insights and engagement strategies.
LEAD, or Leveraging Environmental Assessment Data, is a centralized hub of patient and professional group information across multiple therapeutic areas personalized to help your company identify and prioritize potential partners. It is built to realign priorities as you progress through the drug development continuum.
Health care stakeholder organization landscapes across North America, Latin America, Europe, Asia, and the Middle East
Proprietary algorithmic technology to identify priority organizations based on your specific goals and needs
Database continually updated to reflect changes in executive leadership, financial position, industry partnerships, and other vital details
Personalized recommendations to inform your engagement strategy, including “insider insights” from MK&A’s 15-plus years as a trusted partner to patient and professional communities worldwide
In order to meet the increased demand from our clients for even more analysis and connections to groups in low- and middle-income countries, we enhanced our services by partnering with Catalyst Consulting Group. Catalyst is a global network of consultants who create innovative strategies to raise awareness, mobilize resources, and maximize impact of partnerships with industry in these countries.